Methylation study of a population environmentally exposed to arsenic in drinking water

Environmental Health Perspectives

Volumn 104, Issue 6, 1996, Pages 620-628

  Hopenhayn Rich, Claudia ^a   Biggs, Mary Lou ^a   Smith, Allan H ^a   Kalman, David A ^b   Moore, Lee E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Arsenic; Arsenic methylation; Arsenic speciation; Chile; Water pollution

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; CACODYLIC ACID; DRINKING WATER;

ADULT; AGED; ARTICLE; CHILE; CONTROLLED STUDY; DETOXIFICATION; ENVIRONMENTAL EXPOSURE; ETHNOLOGY; FEMALE; HEALTH HAZARD; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; METABOLITE; METHYLATION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; URINALYSIS; WATER POLLUTION;

EID: 0030016561     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104620     Document Type: Article

References (53)

1. IARC. Arsenic and arsenic compounds. In: IARC monographs on the evaluation of the carcinogenic risk of chemicals ro man, vol 23. Some metals and metallic compounds. Lyon: International Agency for Research on Cancer, 1980:39-141.
2. Bates MN, Smith AH, Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 135:462-476 (1992).
3. Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130:1123-1132 (1989).
4. Chen C-J, Chen CW, Wu M-M, Kuo T-L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888-892 (1992).
5. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan H, Wood R, Kosnett MJ, Smith MT. Cancer risks from arsenic in drinking water. Environ Health Perspect 97:259-267 (1992).
6. U.S. EPA. Special report on ingested inorganic arsenic: skin cancer; nutritional essentiality. EPA 625/3-87/013. Washington, DC:U.S. Environmental Protection Agency, 1988.
7. Vahter M. Species differences in the metabolism of arsenic compounds. Appl Organ Chem 8:175-182 (1994).
8. Marcus WL, Rispin AS. Threshold carcinogenicity using arsenic as an example. In: Advances in modern environmental toxicology: risk assessment and risk management of industrial and environmental chemicals (Cothern CR, Mehlman MA, Marcus WL, eds). Princeton, NJ:Princeton Scientific Publishing Company, 1988;133-158.
9. Carlson-Lynch H, Beck BD, Boardman PD. Arsenic risk assessment. Environ Health Perspect 102:354-356 (1994).
10. Vahter M. Metabolism of arsenic. In: Biological and environmental effects of arsenic (Fowler BA, ed). Amsterdam:Elsevier, 1983:171-198.
11. ATSDR. Toxicological profile for arsenic, update. Report no. TP-92/102. Atlanta, GA:Agency for Toxic Substances and Disease Registry, 1993.
12. Hewitt DJ, Millner GC, Nye AC, Simmons HF. Investigation of arsenic exposure from soil at a Superfund site. Environ Res 68:73-81 (1995).
13. 74As) in humans following oral ingestion. Toxicol Appl Pharmacol 50.319-322 (1979).
14. Buchet JP, Lauwerys R, Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenire by volunteers. Int Arch Occup Environ Health 48:111-118 (1981).
15. Hopenhayn-Rich C, Smith AH, Goeden HM. Human studies do not support the methylation threshold hypothesis for die toxicity of inorganic arsenic. Environ Res 60:161-177 (1993).
16. Warner ML, Moore LE, Smith MT, Kalman DA, Fanning E, Smith AH. Increased micronuclei in exfoliated bladder cells of persons who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev 3:583-590 (1994).
17. Del Razo LM, Hernández JL, García-Vargas GG, Ostrosky-Wegman P, Cortinas de Nava C, Cebrián ME. Urinary excretion of arsenic species in a human population chronically exposed to arsenic via drinking water. A pilot study. In: Arsenic exposure and health (Chappell WR, Abernathy CO, Cothern CR, eds). Northwood, UK:Science and Technology Letters, 1994;91-100.
18. Beck BD, Boardman PD, Hook GC, Rudel RA, Slayton TM, Carlson-Lynch H. Response to Smith et al. [letter]. Environ Health Perspect 103:15-17 (1995).
19. Sancha AM, Vega F, Venturino H, Fuentes S, Salazar AM, Moreno V, Barón AM, Rodríguez D. The arsenic health problem in Northern Chile. Evaluation and control. A case study preliminary report. In: International seminar proceedings arsenic in the environment and its incidence on health (Sancha AM, ed), 25-29 May 1992, Santiago, Chile. Santiago:Universidad de Chile, Facultad de Ciencias Físicas y Matemáticas, 1992;187-202.
20. Alonso, H. Arsenic enrichment in superficial waters. II. Region Northern Chile, In: International seminar proceedings arsenic in the environment and its incidence on health (Sancha AM, ed), 25-29 May 1992, Santiago, Chile. Santiago:Universidad de Chile, Facultad de Ciencias Físicas y Matemálicas, 1992;101-108.
21. Crecelius EA. Modification of the arsenic speciation technique using hybrid generation. Anal Chem 50:826-827 (1978).
22. Atallah R, Kaiman DA. On-line photooxidation for the determination of organoarsenic compounds by atomic absorption spectrophotometry with continuous arsine generation. Talanta 38:167-173 (1991).
23. Boeniger MF, Lowry LK, Rosenerg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 54:615-627 (1993).
24. StataCorp. Stata statistical software: release 4.0. College Station, TX:Stata Corporation, 1995.
25. Georis B, Cardenas A, Buchet JP, Lauwerys R. Inorganic arsenic methylation by rat tissue slices. Toxicology 63:73-84 (1990).
26. Thompson DJ. A chemical hypothesis for arsenic methylation in mammals. Chem-Biol Interactions 88:89-114 (1993).
27. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure, a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159-1164 (1993).
28. Li W, Yang S, Cao Z, Andry CD, Chour IN. Effects of arsenite on the cytoskeleton and cellular GSH in cultured cells. Toxicologist 11:125 (1991).
29. Giralt M, Lafuente A, Pujol F, Mallol J. Enhanced glutathione S-transferase activity and glutathione content in human bladder cancer. Followup study: influence of smoking. J Urol 149:1452-1454 (1993).
30. Hirata M, Tanaka A, Hisanaga A, Ishinishi N. Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on arsenic metabolism in hamsters. Toxicol Appl Pharmacol 106:469-481 (1990).
31. Buchet JP, Lauwerys R. Study of factors influencing the in vivo methylation of inorganic. Toxicol Appl Pharmacol 91:65-74 (1987).
32. Buchet JP, Lauwerys R. Role of thiols in the invitro methylation of inorganic arsenic by rat liver cytosol. Biochem Pharmacol 37:3149-3153 (1988).
33. Bogdan GM, Sampayo-Reyes A, Aposhian HV. Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology 93:175-193 (1994)
34. Del Razo LM, García-Vargas G, Vargas H, Albores A, Cebrián M. Chronic high arsenic exposure alters the profile of urinary arsenic metabolites in humans. Toxicologist 15-262 (1995).
35. Gonsebatt ME, Vega L, Montero R, García-Vargas G, Del Razo LM, Albores A, Cebrián ME, Ostrosky-Wegman P. Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. Mut Res 313:213-299 (1994).
36. Nún̄ez Atencio LN, Hill HG, Martínez AL. Guía Museo Arqueológico, Universidad Católica del Norte Chile. San Pedro de Atacama (II Region): Instituto de Investigaciones Arqueológicas y Museo R.P. Gustavo Le Paige S.J., 1991.
37. Figueroa L, Razmilic B, González M. Corporal distribution of arsenic in mummified bodies owned to an arsenical habitat, In: International seminar proceedings arsenic in the environment and its incidence on health (Sancha AM, ed), 25-29 May 1992, Santiago, Chile. Santiago: Universidad de Chile, Facultad de Ciencias Físicas y Matemáticas, 1992;77-82.
38. Borgoño JM, Vicent P, Venturino H, Infante A. Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environ Health Perspect 19:103-105 (1977).
39. Astolfi E, Besuschio SC. García-Fernández JC, Guerra C, Maccagno A. Hidroarsenicismo crónico regional endémico. Buenos Aires: Cooperativa General Belgrano, 1982.
40. Chatterjee A, Das D, Mandai BK, Chowdhury TR, Samanta G, Chakraborti D. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part I. Arsenic species in drinking water and urine of the affected people. Analyst 120:643-650 (1995).
41. García-Zapata MT, McGreevy PB, Marsden PD. American trypanosomiasis. In: Hunter's tropical medicine, 7th ed. (Strickland GT, ed). Philadelphia: W.B. Saunders Company, 1991;628-637.
42. Aposhian HV, Aposhian MM. Newer developments in arsenic toxicity. J Am Coll Toxicol 8:1297-1305 (1989).
43. Moore MM, Harrington-Brock K, Doerr CL. Genotoxicity of arsenic and its methylated metabolites. In: Arsenic exposure and health (Chappell WR, Abernathy CO, Cothern CR, eds). Northwood, UK:Science and Technology Letters, 1994;191-198.
44. Tu S-H, Shirachi DY. Cytotoxicity of inorganic and organic arsenics in cell culture. Proc West Pharmacol 35:61-63 (1992).
45. Yamauchi H, Fowler BA. Toxicity and metabolism of inorganic and methylated arsenicals. In: Arsenic in the environment part II: human health and ecosystem effects (Nriagu JO, ed). New York:John Wiley and Sons, 1994;35-53.
46. Yamanaka K, Ohba H, Hasegawa A, Sawamura R, Okada S. Mutagenicity of dimethylated metabolites of inorganic arsenics. Chem Pharm Bull 37:2753-2756 (1989).
47. Endo G, Kuroda K, Okamoto A, Horiguchi S. Dimethylarsenic acid induces tetraploids in Chinese hamster cells. Bull Environ Contam Toxicol 48:131-137 (1992).
48. Mass MJ. Human carcinogenesis by arsenic. Environ Geochem Health 14:49-54 (1992).
49. Mushak P, Crocetti A. Risk and revisionism in arsenic cancer risk assessment. Environ Health Perspect 103:684-689 (1995).
50. Weinshilboum R. Pharmacogenetics of methylation: relationship to drug metabolism. Clin Biochem 21:201-210 (1988).
51. Caporaso N, Landi MT, Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics 1:4-19 (1991).
52. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1824 (1993).
53. Sancha AM, Rodríguez D, Vega F, Fuentes S, Lecaros L. Arsenic removal by direct filtration, an example of appropriate technology. In: International seminar proceedings arsenic in the environment and its incidence on health (Sancha AM, ed), 25-29 May 1992, Santiago, Chile. Santiago:Universidad de Chile, Facultad de Ciencias Físicas y Matemáticas, 1992; 165-172.